U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07654257) titled 'Single FrAction Interstitial BreaSt BracHytherApy' on June 11.
Brief Summary: This phase 2, single arm prospective study has been designed to determine the safety of delivering accelerated partial breast irradiation (APBI) with a multicatheter interstitial implant in a single fraction over 1 day. This is a method of delivering radiation therapy directly into or close to a tumor.
Study Start Date: Sept. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Intervention:
DRUG: Partial Breast Irradiation
16 Gy x 1 fraction via multicatheter brachytherapy delivered over 1 day
Recruitment Status: NOT_YET_RECRUITING
Sponso...